```json
{
"content": [
{
"type": "paragraph",
"content": "The Deep Brain Stimulator market outlook remains robust, driven by rising incidence of neurological disorders and advancements in neurosurgical technologies. The market’s attractiveness is bolstered by growing approvals for expanded indications, such as OCD and treatment-resistant depression, and increasing adoption in emerging markets. Competitive intensity is moderate, with established players like Medtronic and Boston Scientific leveraging R&D investments to enhance product portfolios. Strategic collaborations and mergers are intensifying innovation, though emerging players are challenging market leaders with cost-effective solutions. The long-term outlook is optimistic, supported by an aging global population and rising awareness of minimally invasive treatment options. However, high device costs and surgical risks may temper growth in cost-sensitive regions."
},
{
"type": "list",
"title": "Key Drivers and Challenges",
"items": [
{ "text": "Innovation landscape: Rapid advancements in lead-free systems, AI-integrated devices, and non-invasive alternatives are reshaping therapeutic capabilities, though regulatory hurdles may delay commercialization.", "level": 1 },
{ "text": "Demand–supply balance: Current demand outpaces supply due to high manufacturing complexity and limited production capacity, but scaling initiatives are anticipated to address this gap by 2028.", "level": 1 },
{ "text": "Key risk factors: Surgical complications, reimbursement constraints, and geopolitical tensions pose significant threats, particularly in markets with stringent regulatory frameworks.", "level": 1 }
]
}
]
}
```
